Response to Initial Therapy Predicts Clinical Outcomes in Medullary Thyroid Cancer

Response to Initial Therapy Predicts Clinical Outcomes in Medullary Thyroid Cancer

Autor Lindsey, Susan C. Autor UNIFESP Google Scholar
Ganly, Ian Google Scholar
Palmer, Frank Google Scholar
Tuttle, R. Michael Google Scholar
Instituição Universidade Federal de São Paulo (UNIFESP)
Mem Sloan Kettering Canc Ctr
Resumo Background: Risk stratification in medullary thyroid cancer (MTC) has traditionally relied on standardized anatomic staging systems that, despite providing valuable prognostic information, do not adequately predict the risk of persistent or recurrent disease. As dynamic risk stratification has been demonstrated to be clinically valuable in nonmedullary thyroid cancer, we adapted our response to therapy definitions in order to apply them to MTC. in this study, we evaluate and compare the clinical utility of our previously proposed MTC response to therapy stratification with a traditional standardized anatomic staging system.Methods: Both the Tumor, Node, Metastasis/American Joint Cancer Committee (TNM/AJCC) staging system and our previously proposed response to initial therapy staging system was evaluated in 287 MTC patients followed for a median of five years.Results: the TNM/AJCC staging system provided adequate risk stratification with regard to disease-specific mortality and the likelihood of having no evidence of disease at final follow-up, but did not adequately stratify patients with regard to the likelihood of having structural persistent disease, biochemical persistent disease, or recurrence. However, the response to initial therapy risk stratification system provided clinically useful risk stratification with regard to disease-specific mortality, the likelihood of having no evidence of disease at final follow-up, the likelihood of having a biochemical persistent disease at final follow-up, and the likelihood of having structural persistent disease at final follow-up. Furthermore, the response to therapy risk stratification system demonstrated a higher proportion of variance explained (54.3%) than the TNM/AJCC system (23.9%).Conclusion: Our data demonstrate that a dynamic risk stratification system that uses response to therapy variables to adjust risk estimates over time provides more useful clinical prognostic information than static initial anatomic staging in MTC thyroid cancer.
Idioma Inglês
Financiador Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Número do financiamento FAPESP: 09/50575-4
Data de publicação 2015-02-01
Publicado em Thyroid. New Rochelle: Mary Ann Liebert, Inc, v. 25, n. 2, p. 242-249, 2015.
ISSN 1050-7256 (Sherpa/Romeo, fator de impacto)
Publicador Mary Ann Liebert, Inc
Extensão 242-249
Fonte http://dx.doi.org/10.1089/thy.2014.0277
Direito de acesso Acesso restrito
Tipo Artigo
Web of Science WOS:000349012300014
Endereço permanente http://repositorio.unifesp.br/handle/11600/38718

Exibir registro completo




Arquivo

Arquivo Tamanho Formato Visualização

Não existem arquivos associados a este item.

Este item está nas seguintes coleções

Buscar


Navegar

Minha conta